Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Dodd

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Lancet. Respiratory Medicine|November 19, 2023
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trialBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
Lancet (London, England)|September 8, 2020
Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trialToby Richards, Ravishankar Rao Baikady, Ben Clevenger, et al.
The New England Journal of Medicine|December 22, 2022
A 24-Week, All-Oral Regimen for Rifampin-Resistant TuberculosisBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2024
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trialIlaria Motta, Martina Cusinato, Andrew J Ludman, et al.
Lancet (London, England)|August 30, 2023
Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest (ARREST): a UK prospective, multicentre, parallel, randomised clinical trialTiffany Patterson, Gavin D Perkins, Alexander Perkins, et al.
Journal of the American College of Cardiology|May 17, 2024
Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic CardiomyopathySaad M Ezad, Margaret McEntegart, Matthew Dodd, et al.
Lancet (London, England)|December 15, 2019
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trialMichael Mullen, Xu Yu Jin, Anne Child, et al.
European Heart Journal. Acute Cardiovascular Care|October 22, 2025
Expedited transfer to Emergency Department versus Cardiac Catheter Laboratory in a Cardiac Arrest Centre for non ST-elevation Out-Of-Hospital Cardiac Arrest: ARREST Trial as-treated analysisTiffany Patterson, Gavin D Perkins, Matthew Dodd, et al.
Circulation. Cardiovascular Interventions|February 27, 2024
Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled TrialMatthew Ryan, Saad M Ezad, Ian Webb, et al.
The Lancet. Global Health|January 31, 2025
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluationSedona Sweeney, Yoko V Laurence, Catherine Berry, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Lancet. Respiratory Medicine|November 19, 2023
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trialBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
Lancet (London, England)|September 8, 2020
Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trialToby Richards, Ravishankar Rao Baikady, Ben Clevenger, et al.
The New England Journal of Medicine|December 22, 2022
A 24-Week, All-Oral Regimen for Rifampin-Resistant TuberculosisBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2024
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trialIlaria Motta, Martina Cusinato, Andrew J Ludman, et al.
Lancet (London, England)|August 30, 2023
Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest (ARREST): a UK prospective, multicentre, parallel, randomised clinical trialTiffany Patterson, Gavin D Perkins, Alexander Perkins, et al.
Journal of the American College of Cardiology|May 17, 2024
Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic CardiomyopathySaad M Ezad, Margaret McEntegart, Matthew Dodd, et al.
Lancet (London, England)|December 15, 2019
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trialMichael Mullen, Xu Yu Jin, Anne Child, et al.
European Heart Journal. Acute Cardiovascular Care|October 22, 2025
Expedited transfer to Emergency Department versus Cardiac Catheter Laboratory in a Cardiac Arrest Centre for non ST-elevation Out-Of-Hospital Cardiac Arrest: ARREST Trial as-treated analysisTiffany Patterson, Gavin D Perkins, Matthew Dodd, et al.
Circulation. Cardiovascular Interventions|February 27, 2024
Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled TrialMatthew Ryan, Saad M Ezad, Ian Webb, et al.
The Lancet. Global Health|January 31, 2025
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluationSedona Sweeney, Yoko V Laurence, Catherine Berry, et al.
Pageof 6